InSight Crime investigates a contentious deal between major pharmaceutical firm Pisa and the Guatemalan Social Security Institute (or IGSS, as it is known by its Spanish acronym). After the deal, which prosecutors said the IGSS green-lit despite the firm's lack of experience and infrastructure to provide a type of dialysis, dozens of patients with kidney disease died and scores of others suffered infections.
The accused in the IGSS-Pisa case spanned the country's elites, including high-level politicians, the military and Guatemala's powerful private sector. Their trial captivated the nation and provided a stress test for its fragile justice system. The case, though, eventually reached Guatemala's highest courts, where the elites implicated had already bought what some called an insurance policy to make sure they would never face prosecution.
|